- Home
- ZVSA vs SXTP Comparison
ZVSA vs SXTP Comparison
Compare ZVSA & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- SXTP
- Stock Information
- Founded
- ZVSA 2014
- SXTP 2010
- Country
- ZVSA United States
- SXTP United States
- Employees
- ZVSA N/A
- SXTP N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- ZVSA Health Care
- SXTP Health Care
- Exchange
- ZVSA Nasdaq
- SXTP Nasdaq
- Market Cap
- ZVSA 2.5M
- SXTP 2.7M
- IPO Year
- ZVSA N/A
- SXTP 2023
- Fundamental
- Price
- ZVSA $1.49
- SXTP $0.93
- Analyst Decision
- ZVSA Strong Buy
- SXTP Hold
- Analyst Count
- ZVSA 1
- SXTP 1
- Target Price
- ZVSA $240.00
- SXTP N/A
- AVG Volume (30 Days)
- ZVSA 2.1M
- SXTP 1.0M
- Earning Date
- ZVSA 11-14-2024
- SXTP 11-14-2024
- Dividend Yield
- ZVSA N/A
- SXTP N/A
- EPS Growth
- ZVSA N/A
- SXTP N/A
- EPS
- ZVSA N/A
- SXTP N/A
- Revenue
- ZVSA N/A
- SXTP $462,612.00
- Revenue This Year
- ZVSA N/A
- SXTP $141.35
- Revenue Next Year
- ZVSA N/A
- SXTP $175.16
- P/E Ratio
- ZVSA N/A
- SXTP N/A
- Revenue Growth
- ZVSA N/A
- SXTP 128.99
- 52 Week Low
- ZVSA $0.98
- SXTP $0.70
- 52 Week High
- ZVSA $25.00
- SXTP $12.24
- Technical
- Relative Strength Index (RSI)
- ZVSA 61.69
- SXTP 39.26
- Support Level
- ZVSA $1.25
- SXTP $1.26
- Resistance Level
- ZVSA $1.95
- SXTP $1.60
- Average True Range (ATR)
- ZVSA 0.17
- SXTP 0.16
- MACD
- ZVSA 0.05
- SXTP -0.06
- Stochastic Oscillator
- ZVSA 51.58
- SXTP 8.33
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.